MSD Signs a Multiyear Agreement with Just – Evotec Biologics for Gaining Access to J.POD Facility

 MSD Signs a Multiyear Agreement with Just – Evotec Biologics for Gaining Access to J.POD Facility

MSD Signs a Multiyear Agreement with Just – Evotec Biologics for Gaining Access to J.POD Facility

Shots:

  • Just-Evotec to receive $15M up front, milestones on completion of the construction of the J.POD facility (facility of the future) as well as a broad collaboration around reserved capacities
  • Just – Evotec Biologics granted MSD access to manufacturing capacity in the J.POD facility in Redmond, Washington, which was co-developed by MSD and Just Biotherapeutics under 2015 agreement
  • J.POD (manufacturing and plant design) is an integral part of the Just – Evotec Biologics’ J.DESIGN platform that integrates data analytics & ML through all activities involved in the development of biologics

Click here to­ read full press release/ article | Ref: Evotec | Image: Just Biotherapeutics

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post